Notícias

Millions of dollars are available to eligible Chantix buyers, but consumers have until September 14 to submit a claim.

A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment

David Ellison is dangling CNN to appease critics of his massive Warner Bros. Discovery deal, but the attorneys general suing to block it say the offer solves nothing. A September deadline and a seven-figure daily fee are forcing a decision that no single concession can fix.

Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.

Makan Delrahim made the disclosure at Politico’s California Agenda conference, according to Reuters, signaling that Paramount is willing to go beyond internal safeguards to salvage a deal that has become one of the most politically charged media mergers in years. Warner Bros. Discovery is the publicly traded parent of CNN (NASDAQ: WBD), and the merger’s fate directly determines whether Ellison’s Paramount consolidates control over both CBS News and the cable network.

Lilly is trying to protect an experimental obesity medicine from unauthorized sellers before regulators decide whether to approve it.

Coinbase Global Inc. (NASDAQ:COIN) has been swept into New York City’s widening scrutiny of prediction markets, even as the CFTC push back against the state’s attempts to rein in the fast-growing industry. New York City Council Speaker Julie Menin announced...

Customers can expect payouts of up to £70 as part of a landmark group legal case against Mastercard next year after it settled outside court for £200m. Why is Mastercard paying compensation? The global technology company agreed at the end of last year to pay £200m to settle a legal case launched on behalf of UK consumers a decade ago.

Lilly said the products being sold on the black market are unverified, unapproved, and not worth the risk.

Ahead of an approval filing, the drugmaker is amping up a fight against sellers who claim to offer versions of its highly anticipated “triple-G” weight loss medicine.

Shareholders angry over the stock’s decline are alleging fraud with a complaint that has no merit, the payment processor said in its response.

The New York City Council is investigating four prediction markets for alleged deceptive marketing practices and targeting minors, opening a new front in the bitter, state-by-state legal war over prediction-market regulation. City Council Speaker Julie Menin sent letters to Polymarket, Kalshi, Coinbase and Gemini Titan, all of which have a presence in New York City, on Aug. 11 seeking answers about how the companies comply with consumer protection laws. In a letter addressed to Polymarket founder and Chief Executive Shayne Coplan, Menin asked for details about Polymarket promotional videos that appeared to depict fake trades and promoted insider trading on social media.

An appeals court ruled more than 3,000 lawsuits against Meta, Google, TikTok and Snapchat over addictive design claims targeting youth can proceed.

The safety action covers certain Model 3 and Model Y vehicles, while regulators have not finalized a remedy.

According to the National Highway Traffic Safety Administration, the low-beam headlights could be excessively bright, which in turn could make it harder for oncoming motorists to see clearly, increasing the risk of a collision.

The automaker is recalling more than 20,000 vehicles over headlights that may be too bright for oncoming drivers.

The company is fighting to protect itself from liability in multiple cases of social media addiction and a potentially crushing wave of payouts.

Platforms like Meta, TikTok, Snapchat, and Google are facing a long road of litigation.

The appeals court ruled Section 230 provides a liability defense, not immunity, making Meta's appeal premature

By Diana Novak Jones Aug 10 (Reuters) - A U.S. appeals court on Monday allowed thousands of lawsuits to move forward against Meta Platforms, Alphabet's Google, ByteDance's TikTok, and other social

mFLUSIVA is now the first and only mRNA standalone seasonal influenza vaccine on the market, marking a major advancement for the field.

Firefox developer Mozilla is warning that it could be forced to "exit the browser and browser engine markets" if it can no longer receive payment from Google for distributing its search engine.

Dismissal removes one legal challenge involving compounded alternatives while Novo confronts intensifying commercial competition in obesity treatments.

A Texas judge dismissed claims that the drugmakers illegally blocked access to compounded weight-loss drugs.

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI alleging misappropriation of confidential AI and hardware technology trade secrets. The complaint seeks a preliminary injunction that Apple says is needed to prevent irreparable harm to its core AI and device development work. The case could bring internal details of Apple's AI research, product security practices, and development processes into public view. Legal and competitive risks around AI intellectual property are back in focus...

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

Moderna (NASDAQ:MRNA) announced on Thursday that the U. S.

Apple Inc. has asked a U.S. judge to issue a preliminary injunction preventing two former employees and OpenAI from accessing, using, or disclosing alleged confidential information while its trade secrets lawsuit proceeds. Apple asked the court to require former employees...

The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.

Food safety scares and recalls have pressured restaurant and grocery stocks in 2026, raising concerns about costs, supply chains, and brand trust.